Genmab — Januar 2021
-
...med fare for at vække mine trolde - US står i ca 2715 lige nu
-
Understøttet af høj omsætning. Jeg underlader at kommentere på k
ursen usd/dkk
-
Genmab Announces that Janssen has been Granted U.S. FDA Approval for DARZALEX FASPRO
(daratumumab and hyaluronidase-fihj) for Patients with Newly Diagnosed Light-chain (AL) Amyloidosis -
Nice!
-
Troldene inspirerer de mange kommaer - fedt at vi kan holde det på de store linier
-
Gen (dk) er oppe med små 10pct ytd, mens NBI er oppe med 7pct ytd - ser vi GEN følge markedet eller er der noget ekstra krudt i GEN?
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind